Non-invasive imaging of barriers to drug delivery in tumors

Microvascular Research

Volumn 76, Issue 2, 2008, Pages 94-103

  Hassid, Yaron ^a   Eyal, Erez ^a   Margalit, Raanan ^a   Furman Haran, Edna ^a   Degani, Hadassa ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Collagenase; Drug delivery; Interstitial fluid pressure; Lung cancer xenografts; Magnetic resonance imaging

Indexed keywords

COLLAGENASE; GADOLINIUM PENTETATE MEGLUMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; FEMALE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGING SYSTEM; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSURE GRADIENT; PRIORITY JOURNAL; STEADY STATE; TISSUE PRESSURE; TUMOR XENOGRAFT;

ALGORITHMS; ANIMALS; BIOLOGICAL TRANSPORT; CAPILLARIES; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; COLLAGENASES; EXTRACELLULAR FLUID; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASMS, EXPERIMENTAL; PHARMACEUTICAL PREPARATIONS; PRESSURE; TRANSPLANTATION, HETEROLOGOUS;

EID: 49749123449     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2008.06.002     Document Type: Article

References (57)

1. Baish J.W., Netti P.A., and Jain R.K. Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc. Res. 53 2 (1997) 128-141
2. Baxter L.T., and Jain R.K. Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection. Microvasc. Res. 37 1 (1989) 77-104
3. Bhatnagar A., Hustinx R., and Alavi A. Nuclear imaging methods for non-invasive drug monitoring. Adv. Drug Deliv. Rev. 41 1 (2000) 41-54
4. Boucher Y., Baxter L.T., and Jain R.K. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res. 50 15 (1990) 4478-4484
5. Boucher Y., Kirkwood J.M., Opacic D., Desantis M., and Jain R.K. Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res. 51 24 (1991) 6691-6694
6. Brekken C., Bruland O.S., and de Lange Davies C. Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase. Anticancer Res. 20 5B (2000) 3503-3512
7. Brekken C., Hjelstuen M.H., Bruland O.S., and de Lange Davies C. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts. Anticancer Res. 20 5B (2000) 3513-3519
8. Cabebe E., and Wakelee H. Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors. Curr. Treat Options Oncol. 8 1 (2007) 15-27
9. Curti B.D., Urba W.J., Alvord W.G., Janik J.E., Smith II J.W., Madara K., and Longo D.L. Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients: changes during treatment. Cancer Res. 53 10 Suppl (1993) 2204-2207
10. Dadiani M., Margalit R., Sela N., and Degani H. High-resolution magnetic resonance imaging of disparities in the transcapillary transfer rates in orthotopically inoculated invasive breast tumors. Cancer Res. 64 9 (2004) 3155-3161
11. Desmouliere A., Guyot C., and Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int. J. Dev. Biol. 48 5-6 (2004) 509-517
12. Eikenes L., Bruland O.S., Brekken C., and Davies Cde L. Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res. 64 14 (2004) 4768-4773
13. Fukumura D., and Jain R.K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J. Cell Biochem. 101 4 (2006) 937-949
14. Furman-Haran E., Grobgeld D., and Degani H. Dynamic contrast-enhanced imaging and analysis at high spatial resolution of MCF7 human breast tumors. J. Magn. Reson. 128 2 (1997) 161-171
15. Fyles A., Milosevic M., Pintilie M., Syed A., Levin W., Manchul L., and Hill R.P. Long-term performance of interstitial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother. Oncol. 80 2 (2006) 132-137
16. Griffon-Etienne G., Boucher Y., Jain R.K., and Suit H.D. Effects of needle insertion in tumors on interstitial fluid pressure. Microvasc. Res. 54 2 (1997) 174-177
17. Gutmann R., Leunig M., Feyh J., Goetz A.E., Messmer K., Kastenbauer E., and Jain R.K. Interstitial hypertension in head and neck tumors in patients: correlation with tumor size. Cancer Res. 52 7 (1992) 1993-1995
18. Guyton A.C. A concept of negative interstitial pressure based on pressures in implanted perforated capsules. Circ. Res. 12 (1963) 399-414
19. Haider M.A., Sitartchouk I., Roberts T.P., Fyles A., Hashmi A.T., and Milosevic M. Correlations between dynamic contrast-enhanced magnetic resonance imaging-derived measures of tumor microvasculature and interstitial fluid pressure in patients with cervical cancer. J. Magn. Reson. Imaging 25 1 (2007) 153-159
20. Hassid Y., Furman-Haran E., Margalit R., Eilam R., and Degani H. Noninvasive magnetic resonance imaging of transport and interstitial fluid pressure in ectopic human lung tumors. Cancer Res. 66 8 (2006) 4159-4166
21. Heldin C.H., Rubin K., Pietras K., and Ostman A. High interstitial fluid pressure - an obstacle in cancer therapy. Nat. Rev. Cancer 4 10 (2004) 806-813
22. Horsman M.R., Christensen K.L., and Overgaard J. Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure. Int. J. Radiat. Oncol. Biol. Phys. 22 3 (1992) 455-458
23. Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., and Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N. Engl. J. Med. 350 23 (2004) 2335-2342
24. Jain R.K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 47 12 (1987) 3039-3051
25. Jain R.K., and Baxter L.T. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res. 48 24 Pt 1 (1988) 7022-7032
26. Jirtle R.L. Blood flow to lymphatic metastases in conscious rats. Eur. J. Cancer 17 1 (1981) 53-60
27. Katragadda S., Budda B., Anand B.S., and Mitra A.K. Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opin. Drug Deliv. 2 4 (2005) 683-705
28. Koh T.S. On the a priori identifiability of the two-compartment distributed parameter model from residual tracer data acquired by dynamic contrast-enhanced imaging. IEEE Trans. Biomed. Eng. 55 1 (2008) 340-344
29. Leander P., Mansson S., Ege T., and Besjakov J. CT and MR imaging of the liver using liver-specific contrast media. A comparative study in a tumour model. Acta. Radiol. 37 3 Pt 1 (1996) 242-249
30. Lee C.G., Heijn M., di Tomaso E., Griffon-Etienne G., Ancukiewicz M., Koike C., Park K.R., Ferrara N., Jain R.K., Suit H.D., and Boucher Y. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res. 60 19 (2000) 5565-5570
31. Less J.R., Posner M.C., Boucher Y., Borochovitz D., Wolmark N., and Jain R.K. Interstitial hypertension in human breast and colorectal tumors. Cancer Res. 52 22 (1992) 6371-6374
32. Litman T., Druley T.E., Stein W.D., and Bates S.E. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell Mol. Life Sci. 58 7 (2001) 931-959
33. Lyman Ott R., and Longnecker M. Statitical Methods and Data Analysis (2001), Pacific Grove, Duxbury 627-657
34. Manduca A., Oliphant T.E., Dresner M.A., Mahowald J.L., Kruse S.A., Amromin E., Felmlee J.P., Greenleaf J.F., and Ehman R.L. Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med. Image Anal. 5 4 (2001) 237-254
35. Matteucci M.L., Anyarambhatla G., Rosner G., Azuma C., Fisher P.E., Dewhirst M.W., Needham D., and Thrall D.E. Hyperthermia increases accumulation of technetium-99 m-labeled liposomes in feline sarcomas. Clin. Cancer Res. 6 9 (2000) 3748-3755
36. Milosevic M., Fyles A., Hedley D., Pintilie M., Levin W., Manchul L., and Hill R. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res. 61 17 (2001) 6400-6405
37. Mimeault M., Hauke R., and Batra S.K. Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies. Clin. Pharmacol. Ther. 83 5 (2008) 673-691
38. Nathanson S.D., and Nelson L. Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann. Surg. Oncol. 1 4 (1994) 333-338
39. Netti P.A., Baxter L.T., Boucher Y., Skalak R., and Jain R.K. Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery. Cancer Res. 55 22 (1995) 5451-5458
40. Netti P.A., Berk D.A., Swartz M.A., Grodzinsky A.J., and Jain R.K. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res. 60 9 (2000) 2497-2503
41. Netti P.A., Roberge S., Boucher Y., Baxter L.T., and Jain R.K. Effect of transvascular fluid exchange on pressure-flow relationship in tumors: a proposed mechanism for tumor blood flow heterogeneity. Microvasc. Res. 52 1 (1996) 27-46
42. Quinn P.K., Bibby M.C., Cox J.A., and Crawford S.M. The influence of hydralazine on the vasculature, blood perfusion and chemosensitivity of MAC tumours. Br. J. Cancer 66 2 (1992) 323-330
43. Reed R.K., Berg A., Gjerde E.A., and Rubin K. Control of interstitial fluid pressure: role of beta1-integrins. Semin. Nephrol. 21 3 (2001) 222-230
44. Rofstad E.K., Tunheim S.H., Mathiesen B., Graff B.A., Halsor E.F., Nilsen K., and Galappathi K. Pulmonary and lymph node metastasis is associated with primary tumor interstitial fluid pressure in human melanoma xenografts. Cancer Res. 62 3 (2002) 661-664
45. Stone H.B., Minchinton A.I., Lemmon M., Menke D., and Brown J.M. Pharmacological modification of tumor blood flow: lack of correlation between alteration of mean arterial blood pressure and changes in tumor perfusion. Int. J. Radiat. Oncol. Biol. Phys. 22 1 (1992) 79-86
46. Suga K., Mikawa M., Ogasawara N., Okazaki H., and Matsunaga N. Potential of Gd-DTPA-mannan liposome particles as a pulmonary perfusion MRI contrast agent: an initial animal study. Invest. Radiol. 36 3 (2001) 136-145
47. Thomsen H.S. Nephrogenic systemic fibrosis: a serious late adverse reaction to gadodiamide. Eur. Radiol. 16 12 (2006) 2619-2621
48. Thomsen H.S., Marckmann P., and Logager V.B. Nephrogenic systemic fibrosis (NSF): a late adverse reaction to some of the gadolinium based contrast agents. Cancer Imaging 7 (2007) 130-137
49. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J. Magn. Reson. Imaging 7 1 (1997) 91-101
50. Tofts P.S., Berkowitz B., and Schnall M.D. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn. Reson. Med. 33 4 (1995) 564-568
51. Tofts P.S., and Berkowitz B.A. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. Magn. Reson. Imaging 12 1 (1994) 81-91
52. Tofts P.S., Brix G., Buckley D.L., Evelhoch J.L., Henderson E., Knopp M.V., Larsson H.B., Lee T.Y., Mayr N.A., Parker G.J., Port R.E., Taylor J., and Weisskoff R.M. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10 3 (1999) 223-232
53. Tong R.T., Boucher Y., Kozin S.V., Winkler F., Hicklin D.J., and Jain R.K. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res. 64 11 (2004) 3731-3736
54. Wiig H., Reed R.K., and Aukland K. Measurement of interstitial fluid pressure: comparison of methods. Ann. Biomed. Eng. 14 2 (1986) 139-151
55. Wildiers H., Guetens G., De Boeck G., Verbeken E., Landuyt B., Landuyt W., de Bruijn E.A., and van Oosterom A.T. Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11. Br. J. Cancer 88 12 (2003) 1979-1986
56. Willett C.G., Boucher Y., di Tomaso E., Duda D.G., Munn L.L., Tong R.T., Chung D.C., Sahani D.V., Kalva S.P., Kozin S.V., Mino M., Cohen K.S., Scadden D.T., Hartford A.C., Fischman A.J., Clark J.W., Ryan D.P., Zhu A.X., Blaszkowsky L.S., Chen H.X., Shellito P.C., Lauwers G.Y., and Jain R.K. Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat. Med. 10 2 (2004) 145-147
57. Zhao J., Salmon H., and Sarntinoranont M. Effect of heterogeneous vasculature on interstitial transport within a solid tumor. Microvasc. Res. 73 3 (2007) 224-236